Banque Cantonale Vaudoise Lowers Position in The Clorox Company (NYSE:CLX)

Banque Cantonale Vaudoise trimmed its holdings in shares of The Clorox Company (NYSE:CLX) by 29.6% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 23,598 shares of the company’s stock after selling 9,935 shares during the quarter. Banque Cantonale Vaudoise’s holdings in Clorox were worth $3,844,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in CLX. Prospera Financial Services Inc boosted its position in shares of Clorox by 3.1% during the 3rd quarter. Prospera Financial Services Inc now owns 4,549 shares of the company’s stock valued at $742,000 after acquiring an additional 135 shares during the last quarter. Caprock Group LLC lifted its position in Clorox by 9.2% during the third quarter. Caprock Group LLC now owns 2,841 shares of the company’s stock valued at $463,000 after purchasing an additional 239 shares during the last quarter. Aviance Capital Partners LLC grew its stake in Clorox by 2.7% in the 3rd quarter. Aviance Capital Partners LLC now owns 3,080 shares of the company’s stock worth $502,000 after buying an additional 80 shares in the last quarter. Baron Wealth Management LLC bought a new position in shares of Clorox in the 3rd quarter worth $250,000. Finally, Cassaday & Co Wealth Management LLC purchased a new stake in shares of Clorox during the 3rd quarter valued at $231,000. 78.53% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In related news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the transaction, the executive vice president now directly owns 13,471 shares of the company’s stock, valued at $2,229,719.92. This trade represents a 11.40 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.57% of the stock is owned by corporate insiders.

Clorox Trading Down 0.6 %

NYSE:CLX opened at $168.16 on Wednesday. The company has a 50-day moving average price of $162.56 and a 200-day moving average price of $147.94. The stock has a market cap of $20.81 billion, a price-to-earnings ratio of 58.59, a P/E/G ratio of 3.10 and a beta of 0.41. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $169.21.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping the consensus estimate of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The business had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.64 billion. During the same period last year, the business posted $0.49 earnings per share. Clorox’s quarterly revenue was up 27.0% compared to the same quarter last year. Equities analysts predict that The Clorox Company will post 6.85 EPS for the current year.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be paid a $1.22 dividend. This represents a $4.88 annualized dividend and a yield of 2.90%. Clorox’s payout ratio is 170.04%.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on CLX. Deutsche Bank Aktiengesellschaft upped their target price on shares of Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a research report on Friday, August 2nd. TD Cowen raised Clorox from a “sell” rating to a “hold” rating and raised their price objective for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. JPMorgan Chase & Co. upped their target price on Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a research note on Friday, October 11th. Jefferies Financial Group raised shares of Clorox from a “hold” rating to a “buy” rating and lifted their price target for the stock from $174.00 to $187.00 in a research note on Tuesday, October 1st. Finally, DA Davidson upped their price objective on shares of Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a research note on Monday, November 4th. Five research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat.com, Clorox currently has a consensus rating of “Hold” and an average price target of $155.00.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.